Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?

被引:31
作者
Buc, E. [1 ]
Couvelard, A. [2 ]
Kwiatkowski, F. [3 ]
Dokmak, S. [1 ]
Ruszniewski, P. [4 ]
Hammel, P. [4 ]
Belghiti, J. [1 ]
Sauvanet, A. [1 ]
机构
[1] Hop Beaujon, AP HP, Pole Malad Appareil Digestif, Dept Hepatopancreato Biliary Surg, Clichy, France
[2] Hop Beaujon, AP HP, Dept Pathol, Clichy, France
[3] Ctr Jean Perrin, Dept Biostat, Clermont Ferrand, France
[4] Hop Beaujon, AP HP, Pole Malad Appareil Digestif, Dept Gastroenterol, Clichy, France
来源
EJSO | 2014年 / 40卷 / 11期
关键词
Pancreatic cancer; Lymph node; Prognosis; LONG-TERM SURVIVAL; EXTENDED LYMPHADENECTOMY; DUCTAL ADENOCARCINOMA; PERINEURAL INVASION; CANCER; PANCREATICODUODENECTOMY; INVOLVEMENT; GEMCITABINE; IMPACT; RATIO;
D O I
10.1016/j.ejso.2014.04.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lymph node (LN) invasion in pancreatic ductal adenocarcinoma (PDAC) is the most important prognostic factor after surgical resection. The mechanisms of LN invasion include lymphatic spreading and/or direct extension from the main tumor. However, few studies have assessed the impact of these different patterns of invasion on prognosis. Patients and methods: Pathologic reports of pancreatic resections for PDAC from 1997 to 2007 were retrospectively analyzed. The mode of LN invasion was defined as follows: standard lymphatic metastases (S), contiguous from the main tumor (C) and standard with extracapsular invasion (El). Clinical outcomes were compared according to the mode of invasion and the number of invaded LN. Results: 306 patients were reviewed. Median age at resection was 61 years (range, 34-81). Eighty seven patients were N-(28.9%) and 214 were N+ (71.1%). Of the N+ patients, 195 (91.1%) were S+, 35 (16.3%) were C+, and 24 (12.3% of the S+ patients) were EI+. Median survival in N+ patients was lower than in N patients (29 vs. 57 months, p <0.001). In patients without standard involvement, C+ patients (n = 19) had worse survival than C patients (n = 47) (34 vs. 57 months, p = 0.037). In S+ patients, C status was correlated with prognosis when the number of LN S+ was <2 (p = 0.07). El status had no influence on prognosis. On multivariate analysis, only perineural invasion (p = 0.02) and LN ratio (p = 0.042) were independent prognostic factors. Conclusion: Direct invasion of LN by the tumor is predictive of reduced survival, but has little impact compared to standard LN involvement and perineural invasion. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1578 / 1585
页数:8
相关论文
共 31 条
[1]   Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma A Series of 30 Patients Collected From 3 Institutions [J].
Adham, Mustapha ;
Jaeck, Daniel ;
Le Borgne, Joel ;
Oussoultzouglou, Elie ;
Chenard-Neu, Marie-Pierre ;
Mosnier, Jean-Francois ;
Scoazec, Jean-Yves ;
Mornex, Francoise ;
Partensky, Christian .
PANCREAS, 2008, 37 (04) :352-357
[2]   Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer - A united states population-based assessment [J].
Artinyan, Avo ;
Hellan, Minia ;
Mojica-Manosa, Pablo ;
Chen, Yi-Jen ;
Pezner, Richard ;
Ellenhorn, Joshua D. I. ;
Kim, Joseph .
CANCER, 2008, 112 (01) :34-42
[3]  
Berger AC, 2004, AM SURGEON, V70, P235
[4]   Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer -: A Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer Study [J].
Conroy, T ;
Paillot, B ;
François, E ;
Bugat, R ;
Jacob, JH ;
Stein, U ;
Nasca, S ;
Metges, JP ;
Rixe, O ;
Michel, P ;
Magherini, E ;
Hua, A ;
Deplanque, G .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) :1228-1236
[5]   Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer [J].
Farrell, James J. ;
Elsaleh, Hany ;
Garcia, Miguel ;
Lai, Raymond ;
Ammar, Ali ;
Regine, William F. ;
Abrams, Ross ;
Benson, A. Bowen ;
MacDonald, John ;
Cass, Carol E. ;
Dicker, Adam P. ;
Mackey, John R. .
GASTROENTEROLOGY, 2009, 136 (01) :187-195
[6]   Meta-analysis of randomized trials: Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer [J].
Heinemann, Volker ;
Boeck, Stefan ;
Hinke, Axel ;
Labianca, Roberto ;
Louvet, Christophe .
BMC CANCER, 2008, 8 (1)
[7]   The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer [J].
Hellan, Minia ;
Sun, Can-Lan ;
Artinyan, Avo ;
Mojica-Manosa, Pablo ;
Bhatia, Smita ;
Di Ellenhorn, Joshua ;
Kim, Joseph .
PANCREAS, 2008, 37 (01) :19-24
[8]   Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer [J].
House, Michael G. ;
Goenen, Mithat ;
Jarnagin, William R. ;
D'Angelica, Michael ;
DeMatteo, Ronald P. ;
Fong, Yuman ;
Brennan, Murray F. ;
Allen, Peter J. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (11) :1549-1555
[9]  
Kawamata H, 2013, ANTICANCER RES, V33, P583
[10]   Does the Mechanism of Lymph Node Invasion Affect Survival in Patients with Pancreatic Ductal Adenocarcinoma? [J].
Konstantinidis, Ioannis T. ;
Deshpande, Vikram ;
Zheng, Hui ;
Wargo, Jennifer A. ;
Fernandez-del Castillo, Carlos ;
Thayer, Sarah P. ;
Androutsopoulos, Vasiliki ;
Lauwers, Gregory Y. ;
Warshaw, Andrew L. ;
Ferrone, Cristina R. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (02) :261-267